Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer

Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer

Platinum-resistant ovarian cancer (OC) has limited treatment options and is associated with a poor prognosis. There appears to be an overlap between molecular mechanisms responsible for platinum resistance and immunogenicity in OC. Immunotherapy with single agent checkpoint inhibitors has been evalu...

Full description

Bibliographic Details
Main Authors: Alice Indini, Olga Nigro, Csongor György Lengyel, Michele Ghidini, Angelica Petrillo, Salvatore Lopez, Francesco Raspagliesi, Dario Trapani, Shelize Khakoo, Giorgio Bogani
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
platinum-resistance
ovarian cancer
immunotherapy
immune checkpoint inhibitors
new drugs
Online Access:https://www.mdpi.com/2072-6694/13/7/1663

Similar Items

Similar Items